X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Sun Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs SUN PHARMA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD SUN PHARMA WYETH LTD/
SUN PHARMA
 
P/E (TTM) x 27.7 15.0 184.7% View Chart
P/BV x 5.3 3.5 151.6% View Chart
Dividend Yield % 1.3 0.2 586.6%  

Financials

 WYETH LTD   SUN PHARMA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
SUN PHARMA
Mar-16
WYETH LTD/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0441,201 87.0%   
Low Rs818706 115.8%   
Sales per share (Unadj.) Rs298.6117.5 254.2%  
Earnings per share (Unadj.) Rs57.219.6 292.1%  
Cash flow per share (Unadj.) Rs58.423.8 245.4%  
Dividends per share (Unadj.) Rs17.001.00 1,700.0%  
Dividend yield (eoy) %1.80.1 1,740.8%  
Book value per share (Unadj.) Rs249.5130.5 191.2%  
Shares outstanding (eoy) m22.722,406.60 0.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.18.1 38.4%   
Avg P/E ratio x16.348.7 33.4%  
P/CF ratio (eoy) x15.940.1 39.8%  
Price / Book Value ratio x3.77.3 51.1%  
Dividend payout %29.75.1 582.0%   
Avg Mkt Cap Rs m21,1572,294,813 0.9%   
No. of employees `0000.514.7 3.3%   
Total wages/salary Rs m40047,971 0.8%   
Avg. sales/employee Rs Th13,787.419,169.8 71.9%   
Avg. wages/employee Rs Th813.03,253.0 25.0%   
Avg. net profit/employee Rs Th2,643.33,197.9 82.7%   
INCOME DATA
Net Sales Rs m6,783282,697 2.4%  
Other income Rs m3536,170 5.7%   
Total revenues Rs m7,136288,867 2.5%   
Gross profit Rs m1,61783,239 1.9%  
Depreciation Rs m2710,135 0.3%   
Interest Rs m64,769 0.1%   
Profit before tax Rs m1,93874,505 2.6%   
Minority Interest Rs m0-11,126 0.0%   
Prior Period Items Rs m0-19 0.0%   
Extraordinary Inc (Exp) Rs m-5-6,852 0.1%   
Tax Rs m6329,349 6.8%   
Profit after tax Rs m1,30147,159 2.8%  
Gross profit margin %23.829.4 81.0%  
Effective tax rate %32.612.5 260.0%   
Net profit margin %19.216.7 114.9%  
BALANCE SHEET DATA
Current assets Rs m6,984308,646 2.3%   
Current liabilities Rs m2,056132,477 1.6%   
Net working cap to sales %72.662.3 116.6%  
Current ratio x3.42.3 145.8%  
Inventory Days Days9983 119.7%  
Debtors Days Days2488 27.3%  
Net fixed assets Rs m244133,606 0.2%   
Share capital Rs m2272,407 9.4%   
"Free" reserves Rs m5,441266,909 2.0%   
Net worth Rs m5,668314,042 1.8%   
Long term debt Rs m2531,167 0.1%   
Total assets Rs m7,901542,196 1.5%  
Interest coverage x353.316.6 2,125.5%   
Debt to equity ratio x00.1 4.4%  
Sales to assets ratio x0.90.5 164.7%   
Return on assets %16.59.6 172.6%  
Return on equity %22.915.0 152.8%  
Return on capital %34.017.8 191.8%  
Exports to sales %0.214.0 1.6%   
Imports to sales %36.33.1 1,156.8%   
Exports (fob) Rs m1539,572 0.0%   
Imports (cif) Rs m2,4658,882 27.8%   
Fx inflow Rs m1542,171 0.0%   
Fx outflow Rs m2,67721,583 12.4%   
Net fx Rs m-2,66220,588 -12.9%   
CASH FLOW
From Operations Rs m92367,694 1.4%  
From Investments Rs m317-44,549 -0.7%  
From Financial Activity Rs m-481-19,243 2.5%  
Net Cashflow Rs m7593,902 19.5%  

Share Holding

Indian Promoters % 0.0 63.7 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 5.1 220.3%  
FIIs % 7.2 23.0 31.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 8.3 366.3%  
Shareholders   21,978 133,026 16.5%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   TORRENT PHARMA  NATCO PHARMA  DIVIS LABORATORIES  PFIZER  ALKEM LABORATORIES  

Compare WYETH LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WYETH LTD WITH

MARKET STATS